Elite Pharmaceuticals Inc (ELTP)

[rollin2nyte]

http://www.pharmexec.com/pharma-blamed-driving-opioid-abuse-epidemic

"FDA has approved approximately 35 extended-release/long-acting (ER/LA) therapies and five ER products with abuse deterrent features, but these medications are expensive and comprise only 10% of the market. About 90% of opioid prescribing is for some 175 immediate-release (IR) products, including more than 100 generics. One response is to encourage the development of less costly generic versions of long-acting ADFs, as well as and new non-opioid compounds able to manage pain more safely and economically."